Resistance of Haemophilus influenzae isolates in children under 5 years old with acute respiratory infections in China between 2000 and 2002

Journal of International Medical Research

Volumn 35, Issue 4, 2007, Pages 554-563

  Shen, X Z ^a   Lu, Q ^b   Deng, L ^c   Yu, S ^a   Zhang, H ^b   Deng, Q ^c   Jiang, M ^a   Hu, Y ^a   Yao, K H ^a   Yang, Y H ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SHANGHAI CHILDREN S HOSPITAL   (China)

^c Guangzhou Children's Hospital   (China)

Author keywords

Ampicillin resistance; Antimicrobial susceptibility; China; Haemophilus influenzae; Pediatrics; lactamase

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; BETA LACTAMASE; CEFACLOR; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD CARE; CHINA; CHINESE; CLINICAL TRIAL; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS INFLUENZAE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PEDIATRICS; PRESCHOOL CHILD; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION;

EID: 34547940122     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000703500416     Document Type: Article

References (36)

1. Beekmann S, Heilmann K, Richter S, et al: Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002 - 2003. Results of the multinational GRASP Surveillance Program. Int J Antimicrob Agents 2005; 25: 148-156.
2. Brown S, Rybak M: Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001 - 2002, as part of the PROTEKT US study. J Antimicrob Chemother 2004; 54(suppl 1): i7-i15.
3. Jacobs M, Bajaksouzian S, Windau A, et al: Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998 - 2001 US Surveillance Study. Clin Lab Med 2004; 24: 503-530.
4. Mendes C, Kiffer C, Blosser-Middleton R, et al: Antimicrobial susceptibility to levofloxacin and other antibacterial agents among common respiratory pathogens - a Brazilian perspective from the GLOBAL Surveillance Initiative 2001 - 2002. Clin Microbiol Infect 2004; 10: 521-526.
5. Koeth L, Felmingham D, Jacobs M, et al: Antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae in Sao Paulo, Brazil from 1996 to 2000. Int J Antimicrob Agents 2004; 23: 356-361.
6. Reynolds R, Shackcloth J, Felmingham D, et al: Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999 - 2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme. J Antimicrob Chemother 2003; 52: 931-943.
7. Morrissey I, Robbins M, Viljoen L, et al: Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods. J Antimicrob Chemother 2005; 55: 200-208.
8. Perez-Trallero E, Garcia-de-la-Fuente C, Garcia-Rey C, et al: Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain. Antimicrob Agents Chemother 2005; 49: 1965-1972.
9. Hsueh P, Huang W, Shyr J, et al: Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics. J Formos Med Assoc 2004; 103: 664-670.
10. Huang W, Fang S: High prevalence of antibiotic resistance in isolates from the middle meatus of children and adults with acute rhinosinusitis. Am J Rhinol 2004; 18: 387-391.
11. Inoue M, Kaneko K, Akizawa K, et al: Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1 - 3 (1999 - 2002). J Infect Chemother 2006; 12: 9-21.
12. Inoue M, Kohno S, Kaku M, et al: PROTEKT 1999 - 2000: a multicentre study of the antimicrobial susceptibility of respiratory tract pathogens in Japan. Int J Infect Dis 2005; 9: 27-36.
13. Huang HH, Zhang YY, Xiu QY, et al: Community-acquired pneumonia in Shanghai, China: microbial etiology and implications for empirical therapy in a prospective study of 389 patients. Eur J Clin Microbiol Infect Dis 2006; 25: 369-374.
14. O'Callaghan CH, Morris A, Kirby SM, et al: Novel method for detection of β-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother 1972; 1: 283-288.
15. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility test. 6th edn. NCCLS Document M2-A6. Villanova, PA: National Committee for Clinical Laboratory Standards, 1997.
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 12th informational supplement. NCCLS Document M100-S12. Villanova, PA: National Committee for Clinical Laboratory Standards, 2002.
17. Hu Y, Yu S, Liu G, et al: Antimicrobial susceptibility of Haemophilus influenzae among children in Beijing, China, 1999 - 2000. Acta Paediatr 2002; 91: 136-140.
18. Sahm D, Jones M, Hickey M, et al: Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997 - 1998. J Antimicrob Chem 2000; 45: 457-466.
19. Van Kempen M, Vaneechoutte M, Claeys G, et al: Antibiotic susceptibility of acute otitis media pathogens in otitis-prone Belgian children. Eur J Pediatr 2004; 163: 524-529.
20. Nielsen H, Konradsen H, Lous J, et al: Nasopharyngeal pathogens in children with acute otitis media in a low-antibiotic use country, Int J Pediatr Otorhinolaryngol 2004; 68: 1149-1155.
21. Blondeau JM, Suter M, Borsos S, et al: Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumonia and Moraxella catarrhalis. J Antimicrob Chemother 1999; 43(suppl A): 25-30.
22. Gur D, Ozalp M, Sumerkan B, et al: Prevalence of antimicrobial resistance in Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis and Streptococcus pyogenes: results of a multicentre study in Turkey. Int J Antimicrob Agents 2002; 19: 207-211.
23. Inoue M, Lee NY, Hong SW, et al: PROTEKT 1999 - 2000: a multicentre study of the antibiotic susceptibility of respiratory tract pathogens in Hong Kong, Japan and South Korea. Int J Antimicrob Agents 2004; 23: 44-51.
24. Hsueh PR, Liu YC, Shyr JM, et al: Multicenter surveillance of antimicrobial resistance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan during the 1998 - 1999 respiratory season. Antimicrob Agents Chemother 2000; 44: 1342-1345.
25. Stratchounski L, Kretchikova O, Reshedko G, et al: Antimicrobial susceptibility of nasopharyneal isolates of Haemophilus influenzae from healthy children in day-care centers. Results of multicentre study in Russia. Int J Antimicrob Agents 2001; 18: 347-351.
26. Hoban D, Felmingham D: The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. J Antimicrob Chemother 2002; 50(suppl 1): 49-59.
27. Bell J, Turnidge J, Jones R, et al: Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program (1998 - 1999), including an in vitro evaluation of BMS284756. Int J Antimicrob Agents 2002; 19: 125-132.
28. Abdel-Rahman E, Ismael N, Dixon R: Antibiotic resistance and prevalence of beta-lactamase in Haemophilus influenzae isolates - a surveillance study of patients with respiratory infection in Saudi Arabia. Diagn Microbiol Infect Dis 2000; 36: 203-208.
29. Hoban D, Biedenbach D, Mutnick A, et al: Pathogen occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY antimicrobial surveillance study (2000). Diagn Microbial Infect Dis 2003; 45: 279-285.
30. White A, Kaye C, Poupard J, et al: Augmentin (amoxicillin/ clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. J Antimicrob Chemother 2004; 53(suppl 1): i3-i20.
31. Hsueh P, Chen W, Luh K: Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991 - 2003 at a university hospital in Taiwan. Int J Antimicrob Agents 2005; 26: 463-472.
32. Hsueh P, Chen W, Teng L, et al: Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents, Int J Antimicrob Agents 2005; 26: 43-49.
33. Ampos J, Roman F, Perez-Vazquez M, et al: Antibiotic resistance and clinical significance of Haemophilus influenzae type f. J Antimicrob Chemother 2003; 52: 961-966.
34. Okeke I, Laxminarayan R, Bhutta Z, et al: Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 2005; 5: 481-493.
35. Busani L, Del Grosso M, Paladini C, et al: Antimicrobial susceptibility of vancomycin-susceptible and -resistant enterococci isolated in Italy from raw meat products, farm animals, and human infections, Int J Food Microbiol 2004; 97: 17-22.
36. Guardabassi L, Schwarz S, Lloyd D: Pet animals as reservoirs of antimicrobial-resistant bacteria. J Antimicrob Chemother 2004; 54: 321-332.